Promise seen for drug in patients with early Alzheimer's

Washington (AFP) - A new kind of drug to fight Alzheimer's has shown promise when given to people in the early stages of the disease, drug-maker Eli Lilly said Wednesday.

Known as solanezumab, the drug is a monoclonal antibody that helps the brain clear amyloid-beta before it clumps together to form plaques that are implicated in Alzheimer's, which affects 44 million people living with dementia worldwide, and has no effective treatment.

In 2012, solanezumab was shown to be no better than...

What feeling does this article give you?

#hashtags to follow:

Washington [+]    AFP [+]    Alzheimer [+]    Eli Lilly [+]   

More #news: